泰林生物 (300813.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(泰林生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 45.0037.0051.0060.0052.0047.0052.0059.0057.00
 单季度销售净利率(%) 7.00-3.00-4.009.0022.0023.0018.0023.0019.00
 单季度净资产收益率ROE(%) 1.00--1.003.005.003.003.003.00
 单季度总资产净利率ROA(%) 1.00--1.002.003.002.002.002.00
单季度财务摘要:
 单季度营业总收入(元) 80,006,616.0066,738,457.0060,631,217.0063,539,832.0078,946,553.00140,162,722.0088,015,315.0074,165,320.0071,534,758.00
 单季度营业总成本(元) 77,318,178.0070,702,640.0067,901,429.0060,477,378.0064,924,391.00119,002,980.0074,896,194.0061,612,917.0056,632,371.00
 单季度营业收入(元) 80,006,616.0066,738,457.0060,631,217.0063,539,832.0078,946,553.00140,162,722.0088,015,315.0074,165,320.0071,534,758.00
 单季度营业利润(元) 5,839,770.00-915,087.00-1,490,784.006,123,086.0018,061,320.0030,104,495.0016,131,213.0018,577,345.0014,799,500.00
 单季度利润总额(元) 5,915,782.00-902,710.00-1,900,245.006,659,138.0018,119,743.0030,356,537.0016,150,061.0018,550,169.0014,890,543.00
 单季度净利润(元) 5,541,205.00-2,320,503.00-2,240,917.005,431,586.0017,575,026.0032,426,208.0015,961,192.0017,373,623.0013,925,179.00
 单季度归属母公司股东的净利润(元) 5,873,081.00-1,643,001.00-1,882,071.005,618,997.0017,575,026.0032,426,208.0015,961,192.0017,373,623.0013,925,179.00
 单季度经营活动产生的现金流量(元) -6,296,393.0014,442,567.00-2,535,141.007,831,574.00-17,807,115.0059,357,619.0022,672,250.009,858,299.00-2,502,548.00
 单季度投资活动产生的现金流量(元) 386,291.00-149,983,112.0068,679,014.00-29,292,774.00-61,746,781.0043,061,760.00-40,975,512.00-110,870,010.00-55,585,743.00
 单季度筹资活动产生的现金流量(元) --31,826,036.0029,545,596.00-11,292,236.00-9,908.00-52,058,702.0047,815,014.00-16,376,229.00204,469,340.00
 单季度现金及现金等价物净增加(元) -5,893,232.00-166,945,465.0095,696,173.00-32,880,239.00-79,563,805.0050,306,978.0029,538,451.00-117,414,638.00146,371,343.00

前瞻产业研究院